Healthcare Services

Breath Biopsy Testing Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

May 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Breath Biopsy Testing Market By 2030 Based On Its 2026 Value?

The bronchitis treatment market has experienced robust expansion in recent years. It is anticipated to increase from $5.92 billion in 2025 to $6.37 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.5%. The historical growth can be ascribed to elements such as the growing occurrence of respiratory infections, historically rising smoking rates, exposure to urban air pollution, the widespread adoption of bronchodilators and antibiotics, and established hospital-based respiratory care models.

The bronchitis treatment market is projected to experience robust expansion over the coming years. This market is set to reach a valuation of $8.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period stems from factors such as a heightened emphasis on preventive respiratory care, the increasing uptake of digital inhalers, the broader availability of telehealth services for respiratory conditions, an expanding senior demographic, and improved understanding of how to manage chronic respiratory diseases. Key developments expected during this period involve a greater reliance on combination drug regimens, a surge in the use of inhalation-based therapies, an intensified focus on strategies for symptom management, the proliferation of home-based respiratory care options, and more sophisticated monitoring for individuals with chronic bronchitis.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

Which Strategic Drivers Are Supporting The Breath Biopsy Testing Market Development?

The anticipated rise in respiratory disease cases is projected to drive the expansion of the bronchitis treatment market in the future. Respiratory illnesses are defined as conditions impacting the lungs and other components of the respiratory system. These conditions may target either the upper or lower respiratory tract and stem from various elements such as infections, allergens, irritants, and inherited susceptibilities. The approach to bronchitis treatment for respiratory diseases varies based on the underlying cause and the severity of the ailment. Common bronchitis treatments encompass antibiotics, anti-inflammatory medications, and bronchodilators designed to open the airways within respiratory organs. For example, data from June 2025 by Public Health Wales and National Health Service Wales, a U.K.-based national public health agency, indicated that in 2023/24, around 237,400 individuals were diagnosed with asthma and 75,600 with chronic obstructive pulmonary disease (COPD). Projections suggest these figures will increase to approximately 256,400 asthma cases and 84,800 COPD cases by 2033/34, underscoring a consistent increase in the prevalence of respiratory diseases. Consequently, the rising occurrence of respiratory illnesses is fueling the expansion of the bronchitis treatment market moving forward.

What Key Segment Areas Are Included In The Breath Biopsy Testing Market Assessment?

The breath biopsy testing market covered in this report is segmented –

1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

Subsegments:

1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

Which Trends Are Affecting The Breath Biopsy Testing Market Framework?

Leading companies in the bronchitis treatment market are innovating technologies such as dry powder inhalers (DPI) to heighten drug delivery precision, optimize dosing, and elevate the overall patient experience by making bronchitis treatment more accessible and user-friendly for individuals. Dry Powder Inhalers (DPI) function as devices that dispense medication in a dry powder form directly into the lungs, thereby enabling effective therapy for respiratory conditions. For example, in November 2023, Lupin Limited, an India-based pharmaceutical company, unveiled Vilfuro-G. Vilfuro-G incorporates three active components, namely vilanterol, fluticasone furoate, and glycopyrronium bromide, within a single inhaler. This specific blend is formulated to deliver holistic management of COPD symptoms, simultaneously addressing inflammation, bronchoconstriction, and mucus production.

Which Companies Are Engaged In The Breath Biopsy Testing Market Environment?

Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

Access The Complete Breath Biopsy Testing Market Report:

https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

Which Area Represents The Largest Portion Of The Breath Biopsy Testing Market?

North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Breath Biopsy Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=19351&type=smp

Browse Through More Reports Similar to the Global Breath Biopsy Testing Market 2026, By The Business Research Company

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Liquid Biopsy For Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Smart Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795